ON
← Back to feed
US study tests psilocybin to fight cancer side effects
United Kingdom🏛️ PoliticsLean Progressiveyesterday

US study tests psilocybin to fight cancer side effects

A U.S. study published in the journal Science explored the potential of psilocybin, the active compound in magic mushrooms, to alleviate the painful side effects of chemotherapy known as peripheral neuropathy. Researchers tested the substance on rats and human tissue, discovering that psilocybin could protect nerve cells and prevent the development of neuropathy by maintaining mitochondrial function and neural activity. The findings suggest that psilocybin might reduce nerve damage caused by chemotherapy, potentially improving patient outcomes and allowing for more aggressive treatments. However, experts caution that further research is needed to confirm safety and efficacy in humans before clinical applications can begin.

Advertisement

Go to the primary sources (4)

The official sources this coverage is built on. Read them directly to bypass framing.

2 reports

Phys.org logoPhys.orgIndependentCenteryesterday
US study tests psilocybin to fight cancer side effects

A U.S. study published in the journal Science explored the potential of psilocybin, the active compound in magic mushrooms, to alleviate the painful side effects of chemotherapy known as peripheral neuropathy. Researchers tested the substance on rats and human tissue, discovering that psilocybin could protect nerve cells and prevent the development of neuropathy by maintaining mitochondrial function and neural activity. The findings suggest that psilocybin might reduce nerve damage caused by chemotherapy, potentially improving patient outcomes and allowing for more aggressive treatments. However, experts caution that further research is needed to confirm safety and efficacy in humans before clinical applications can begin.

Bias read (Center): The article presents scientific findings without overt ideological framing. While psilocybin is a controversial substance due to its psychoactive properties and legal status, the focus remains on medical research and clinical implications rather than political advocacy. The tone is objective, citing

Nature News logoNature NewsIndependentProgressive4 days ago
Magic-mushroom compound blocks a severe side effect of chemotherapy in mice

A study conducted on mice suggests that psilocybin, a psychoactive compound found in magic mushrooms, may prevent chemotherapy-induced neuropathy. Researchers observed that administering two doses of psilocybin before chemotherapy significantly reduced the development of neuropathy, which affects up to 60% of patients receiving platinum-based cancer treatments. The findings, published in 'Science', indicate that psilocybin might protect nerve fibers by improving mitochondrial function, potentially offering a new preventive strategy for managing this painful side effect. The research highlights a novel application of psilocybin beyond its traditional associations with mental health conditions.

Bias read (Progressive): The article frames psilocybin as a potential medical breakthrough with therapeutic implications, emphasizing its role in preventing a serious side effect of chemotherapy. While the scientific findings are presented objectively, the focus on psilocybin's medicinal benefits aligns with progressive or左

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories